The panel addressed the role of the buy-side board of directors in mergers and acquisitions (M&A) transactions, focusing on communication between management and the board, evaluation of a transaction in the context of capital allocation, effective strategies for integration of an acquired company, and the keys to being a successful strategic buyer. The panel also highlighted recent M&A trends.
The panel was moderated by Foley Partner Steven Hilfinger as well as Bryan Armstrong of FD/Ashton Partners and Justin Friesen of UBS Securities. Panelists were Chris Brown of TechTeam Global and David Drury of Poblocki Sign Company.
Related Insights
July 15, 2025
Innovative Technology Insights
Navigating FDA’s Proposed Guidance on AI and Non-Animal Models: Safeguarding Innovation in Drug Development
In April 2025, the U.S. Food and Drug Administration (FDA) released a landmark guidance titled “Roadmap to Reducing Animal Testing in…
July 15, 2025
Health Care Law Today
Navigating FDA’s Proposed Guidance on AI and Non-Animal Models: Safeguarding Innovation in Drug Development
In April 2025, the U.S. Food and Drug Administration (FDA) released a landmark guidance titled “Roadmap to Reducing Animal Testing in…
July 15, 2025
Health Care Law Today
Colorado Medicaid: RAC Program Overhauled with Enhanced Transparency, Greater Provider Protections, and Increased Oversight
In June 2025, Colorado passed a new law that makes significant changes to the state’s Medicaid Recovery Audit Contractor (RAC) program….